Trelegy ellipta 100-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB26FY1T8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,437
Award facts
- Contract value 100% obligated
- $4,436.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count), with a ceiling value of $4,436.68 and an ultimate completion date of October 31, 2025. This non-set-aside, firm fixed-price delivery order represents a small-value pharmaceutical procurement under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
This delivery order is executed under AmerisourceBergen Drug Corp's comprehensive prime vendor contract with the Defense Logistics Agency, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. Trelegy Ellipta is a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease and asthma, representing the type of specialty pharmaceutical products the company routinely delivers to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains a significant presence in federal medical procurement and has demonstrated capability to fulfill federal requirements through competitive award processes.
Quick answers
Who was awarded contract SPE2DB26FY1T8?
SPE2DB26FY1T8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FY1T8 worth?
The government has obligated $4,437 on SPE2DB26FY1T8.
Is contract SPE2DB26FY1T8 an order under another contract?
Yes. SPE2DB26FY1T8 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB26FY1T8 competed?
The extent of competition for SPE2DB26FY1T8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award